期刊文献+

大肠杆菌表达的戊型肝炎病毒ORF2多肽对恒河猴的免疫保护研究 被引量:22

The Immuno-protect Study of a Hepatitis E Virus ORF2 Peptide Expressed in E.coli
下载PDF
导出
摘要 在大肠杆菌中表达的一段戊型肝炎病毒 (HEV)结构蛋白NE2 ,纯化后以弗氏佐剂 ,按0d ,1 0d ,30d的方案 1 0 μg 针的剂量免疫 3只恒河猴 ,在第 2周抗体阳转 ,第 6周时 1只滴度达 1∶1 0 0 0 0 0 ,另 2只滴度 1∶2 0 0 0 0 ,此时以 1 0 6PCR滴度的HEV病毒粪悬液攻击。对照组 3只均出现血清转氨酶 (ALT)升高 ,抗体阳转 ,粪便持续排毒 1月以上 ;疫苗组无一发病 ,未检出非疫苗来源的抗体 ,其中 1只始终未检出粪便排毒 ,另 2只仅出现短暂排毒。以一份NE2免疫后猴血清 (滴度 1∶2 0 0 0 0 )与 1 0 3PCR滴度的病毒混匀后感染 2只恒河猴 ,结果对照组 2只均持续排毒 3周以上 ,抗体阳转 ,1只ALT明显升高 ;而抗体中和组 2只猴始终未检出粪便排毒 ,抗NE2抗体缓慢下降 ,ALT正常。这些结果表明NE2具有良好的免疫原性和免疫保护性 ,有可能成为有效的戊肝疫苗。 A hepatitis E virus (HEV) ORF2 peptide expressed in an unfused pattern in E. coli, NE2, can self-assembly into homodimers and oligomers, and the immuno-reactivity of the dimers or oligomers to HEV infected serum is much stronger than monomer, which suggested that some important conformational epitopes be better exposed in dimer or oligomer form. Three Rhesus monkeys were vaccinated with three doses (10μg/dose) purified NE2 in Freud's adjuvant under a schedule of 0d, 10d, and 30d. Specific antibodies can be detected on second week, and on sixth week while virus challenge were performed with 106 PCR titer of virus positive stool suspention, the antibody titer of one monkey was 1∶100 000, the other two were both 1∶20 000. Three monkeys in control group presented typical acute hepatitis E manifestation: increased seral amino transferase (ALT), antibody conversion, and continuous virus excretion in stool. In contrast, the ALT of monkeys in vaccinated group continued to be normal, stool virus had not been detected in one monkey, and presented only a short duration in another two. One NE2-vaccinated monkey serum with antibody titer 1: 20 000 was first incubated with HEV (103 PCR titer) for neutralization, then the mixture were used to challenge two monkeys, the results showed that two monkeys in control group continued to excrete virus for more than three weeks, sera antibody conversion, and one monkey presented obvious ALT increase. Both two monkeys challenged with antibody neutralized virus had not detected virus in stool, the antibodies decreased slowly, and ALT continued to be normal. These results suggested that the prokaryotic expression recombinant protein NE2 have good immunogenicity and immunoprotectivity, and should be a good candidate for an effective hepatitis E vaccine.
出处 《微生物学报》 CAS CSCD 北大核心 2003年第1期35-42,共8页 Acta Microbiologica Sinica
关键词 大肠杆菌 基因表达 戊型肝炎病毒 ORF2多肽 恒河猴 免疫保护 Hepatitis E virus, Vaccine, Animal protection, Prokaryotic expression
  • 相关文献

参考文献21

  • 1Zhuang H, Cao X Y, Liu C B, et al. Epidemiology of hepatitis E in China. Gastroenterologia Japonica, 1999, 36(suppl3): 135~138.
  • 2Irshad M. Hepatitis E virus: an update on its molecular, clinical and epidemiological characteristics. Intervirology, 1999, 42:252~62
  • 3Zhang J Z, Ng M H, Xia N S, et al. Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J Med Virol, 2001, 64:125~132
  • 4Im S W, Zhang J Z, Zhuang H, et al. A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus. Vaccine, 2001, 19:3726~3732
  • 5李少伟,张军,何志强,葛胜祥,顾颖,林鉴,刘如石,夏宁邵.大肠杆菌表达的戊型肝炎病毒ORF2片段的聚合现象研究[J].生物工程学报,2002,18(4):463-467. 被引量:37
  • 6冯仁伟.血清谷丙转氨酶测定[A].上海市医学化验所主编.临床生化检验(上册)[C].上海:上海科技出版社,1979.333-335.
  • 7Purdy M A, McCaustland K A, Krawczynski K, et al. Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV). J Med Virol, 1993,41:90~94.
  • 8Robinson R A, Burgess W H, Emerson S U, et al. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expression Purification, 1998, 12:75~84.
  • 9Tsarev S A, Tsareva T S, Emerson S U, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A. 1994, 91: 10198 ~10202.
  • 10Tsarev S A, Tsareva T S, Emerson S U, et al. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge.Vaccine. 1997, 15:1834~1838.

二级参考文献15

  • 1庄辉,李凡,朱永红,朱万孚,郭晓霞.戊型肝炎病人和实验感染戊型肝炎病毒的猕猴血清抗-HEV ORF2和ORF3的动态变化[J].中华实验和临床病毒学杂志,1995,9(4):299-302. 被引量:6
  • 2田庚善.关于戊型病毒性肝炎的血清学诊断问题[J].中华医学杂志,1996,76(1):7-8. 被引量:5
  • 3朱晓洁 庄辉 等.套式逆转录聚合酶链反应检测戊型肝炎病毒(HEV)RNA[J].中华预防医学杂志,1996,30:1-3.
  • 4Tsarev S A,Tsareva T S,Emerson S U et al.ELISA for antibody to hepatitis E virus (HEV) based on complete open - reading frame - 2 protein expressed in insect cells: identification of HEV infection in primates.J Infect Dis,1993,168:369~378
  • 5McAtee C P,Zhang Y,Yarbough P O et al.Parification of a soluble hepatitis E open reading frame 2 - derived protein with unique antigenic properties.Protein Expr Purif,1996,8:262~270
  • 6Li T,Yamakawa Y,Suzuki K et al.Expression and self-assembly of empty virus - -like particles of hepatitis E virus.J Virol,1997,71:7207~7213
  • 7Robinson R A,Burgess W H,Emerson S U et al.Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells.Protein Expr Purif,1998,12:75~84
  • 8Xing L,Kato K,Li T et al.Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes.Virology,1999,265:35~45
  • 9Zhang J Z,Ng M H,Xia N S et al.Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein.J Med Virol,2001,64:125~132
  • 10Im S,Zhang J Z,Zhuang H et al.A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus.Vaccine,2001,19:3726~3732

共引文献79

同被引文献181

引证文献22

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部